Logo image of UFPT

UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis

NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock

274.3  +9.26 (+3.49%)

Premarket: 273 -1.3 (-0.47%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to UFPT. UFPT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. UFPT scores excellent on profitability, but there are some minor concerns on its financial health. UFPT is not overvalued while it is showing excellent growth. This is an interesting combination. This makes UFPT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
UFPT had a positive operating cash flow in the past year.
Each year in the past 5 years UFPT has been profitable.
In the past 5 years UFPT always reported a positive cash flow from operatings.
UFPT Yearly Net Income VS EBIT VS OCF VS FCFUFPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

1.2 Ratios

UFPT has a better Return On Assets (8.49%) than 90.00% of its industry peers.
With an excellent Return On Equity value of 16.47%, UFPT belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
UFPT has a better Return On Invested Capital (10.61%) than 91.58% of its industry peers.
UFPT had an Average Return On Invested Capital over the past 3 years of 9.40%. This is in line with the industry average of 8.08%.
The 3 year average ROIC (9.40%) for UFPT is below the current ROIC(10.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.49%
ROE 16.47%
ROIC 10.61%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%
UFPT Yearly ROA, ROE, ROICUFPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

UFPT has a Profit Margin of 11.74%. This is amongst the best in the industry. UFPT outperforms 88.42% of its industry peers.
In the last couple of years the Profit Margin of UFPT has grown nicely.
Looking at the Operating Margin, with a value of 15.83%, UFPT belongs to the top of the industry, outperforming 86.84% of the companies in the same industry.
In the last couple of years the Operating Margin of UFPT has grown nicely.
The Gross Margin of UFPT (28.31%) is worse than 76.32% of its industry peers.
In the last couple of years the Gross Margin of UFPT has grown nicely.
Industry RankSector Rank
OM 15.83%
PM (TTM) 11.74%
GM 28.31%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%
UFPT Yearly Profit, Operating, Gross MarginsUFPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

6

2. Health

2.1 Basic Checks

UFPT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for UFPT has been increased compared to 5 years ago.
Compared to 1 year ago, UFPT has an improved debt to assets ratio.
UFPT Yearly Shares OutstandingUFPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
UFPT Yearly Total Debt VS Total AssetsUFPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

UFPT has an Altman-Z score of 6.05. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.05, UFPT belongs to the best of the industry, outperforming 81.05% of the companies in the same industry.
The Debt to FCF ratio of UFPT is 4.67, which is a neutral value as it means it would take UFPT, 4.67 years of fcf income to pay off all of its debts.
UFPT has a better Debt to FCF ratio (4.67) than 82.11% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that UFPT is somewhat dependend on debt financing.
UFPT has a worse Debt to Equity ratio (0.61) than 66.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Altman-Z 6.05
ROIC/WACC1.15
WACC9.2%
UFPT Yearly LT Debt VS Equity VS FCFUFPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

UFPT has a Current Ratio of 2.57. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of UFPT (2.57) is comparable to the rest of the industry.
UFPT has a Quick Ratio of 1.43. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT's Quick ratio of 1.43 is on the low side compared to the rest of the industry. UFPT is outperformed by 61.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.43
UFPT Yearly Current Assets VS Current LiabilitesUFPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

More info and screens

7

3. Growth

3.1 Past

UFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.86%, which is quite impressive.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
The Revenue has grown by 18.48% in the past year. This is quite good.
The Revenue has been growing by 16.00% on average over the past years. This is quite good.
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%

3.2 Future

UFPT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.49% yearly.
The Revenue is expected to grow by 17.77% on average over the next years. This is quite good.
EPS Next Y29.29%
EPS Next 2Y22.31%
EPS Next 3Y19.49%
EPS Next 5YN/A
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
UFPT Yearly Revenue VS EstimatesUFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
UFPT Yearly EPS VS EstimatesUFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.13, which means the current valuation is very expensive for UFPT.
Based on the Price/Earnings ratio, UFPT is valued a bit cheaper than the industry average as 71.05% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of UFPT to the average of the S&P500 Index (28.29), we can say UFPT is valued slightly more expensively.
UFPT is valuated quite expensively with a Price/Forward Earnings ratio of 31.34.
74.21% of the companies in the same industry are more expensive than UFPT, based on the Price/Forward Earnings ratio.
UFPT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.13
Fwd PE 31.34
UFPT Price Earnings VS Forward Price EarningsUFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UFPT is valued a bit cheaper than 75.26% of the companies in the same industry.
UFPT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UFPT is cheaper than 77.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.28
EV/EBITDA 26.71
UFPT Per share dataUFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

UFPT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 19.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)1.72
EPS Next 2Y22.31%
EPS Next 3Y19.49%

More info and screens

0

5. Dividend

5.1 Amount

UFPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UFP TECHNOLOGIES INC

NASDAQ:UFPT (1/21/2025, 8:00:02 PM)

Premarket: 273 -1.3 (-0.47%)

274.3

+9.26 (+3.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst OwnersN/A
Inst Owner Change0.72%
Ins OwnersN/A
Ins Owner Change-0.12%
Market Cap2.10B
Analysts80
Price Target388.62 (41.68%)
Short Float %9.78%
Short Ratio7.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)12.38%
Max EPS beat(2)14.29%
EPS beat(4)4
Avg EPS beat(4)25.88%
Min EPS beat(4)12.38%
Max EPS beat(4)46.43%
EPS beat(8)7
Avg EPS beat(8)18.43%
EPS beat(12)11
Avg EPS beat(12)34.1%
EPS beat(16)14
Avg EPS beat(16)30.76%
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)0.98%
Max Revenue beat(2)7.43%
Revenue beat(4)4
Avg Revenue beat(4)4.87%
Min Revenue beat(4)0.98%
Max Revenue beat(4)7.43%
Revenue beat(8)7
Avg Revenue beat(8)3.66%
Revenue beat(12)11
Avg Revenue beat(12)6.82%
Revenue beat(16)14
Avg Revenue beat(16)5.61%
PT rev (1m)0%
PT rev (3m)0.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.83%
EPS NY rev (1m)0%
EPS NY rev (3m)5.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)25.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.72%
Valuation
Industry RankSector Rank
PE 39.13
Fwd PE 31.34
P/S 4.56
P/FCF 46.28
P/OCF 38.34
P/B 6.39
P/tB N/A
EV/EBITDA 26.71
EPS(TTM)7.01
EY2.56%
EPS(NY)8.75
Fwd EY3.19%
FCF(TTM)5.93
FCFY2.16%
OCF(TTM)7.15
OCFY2.61%
SpS60.21
BVpS42.91
TBVpS-1.34
PEG (NY)1.34
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 8.49%
ROE 16.47%
ROCE 13.05%
ROIC 10.61%
ROICexc 10.93%
ROICexgc 29.09%
OM 15.83%
PM (TTM) 11.74%
GM 28.31%
FCFM 9.84%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%
ROICexc(3y)9.58%
ROICexc(5y)9.84%
ROICexgc(3y)21.67%
ROICexgc(5y)20.24%
ROCE(3y)11.55%
ROCE(5y)11.63%
ROICexcg growth 3Y23.9%
ROICexcg growth 5Y9.52%
ROICexc growth 3Y17.37%
ROICexc growth 5Y6.42%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Debt/EBITDA 2.32
Cap/Depr 72.29%
Cap/Sales 2.04%
Interest Coverage 14.27
Cash Conversion 63.72%
Profit Quality 83.86%
Current Ratio 2.57
Quick Ratio 1.43
Altman-Z 6.05
F-Score5
WACC9.2%
ROIC/WACC1.15
Cap/Depr(3y)90.69%
Cap/Depr(5y)79.13%
Cap/Sales(3y)3.04%
Cap/Sales(5y)2.9%
Profit Quality(3y)44.68%
Profit Quality(5y)83.37%
High Growth Momentum
Growth
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
EPS Next Y29.29%
EPS Next 2Y22.31%
EPS Next 3Y19.49%
EPS Next 5YN/A
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y30.99%
EBIT growth 3Y49.79%
EBIT growth 5Y22.92%
EBIT Next Year74.72%
EBIT Next 3Y31.27%
EBIT Next 5YN/A
FCF growth 1Y496.37%
FCF growth 3Y14.27%
FCF growth 5Y14.19%
OCF growth 1Y11575.1%
OCF growth 3Y18.18%
OCF growth 5Y14.16%